NCT03612479

Brief Summary

This is an ancillary study to KIDFIT (NCT03405246). KIDFIT tests whether preschool-age children, born to overweight or obese mothers, respond to a healthy DASH diet intervention with better cardiovascular health. This ancillary study to KIDFIT investigates how the children's gut microbiomes (bacteria in the intestines) and blood metabolomes (small molecules in the blood) are affected by the DASH diet intervention, and how the microbiome and metabolome relate to the children's cardiovascular health over time. The investigators hypothesize that (1) the DASH diet will modify the gut microbiome and blood metabolome, (2) the gut microbiome and blood metabolome will be related to each other, and (3) the microbiome and metabolome will be associated with the children's cardiovascular health profiles (things like weight, body fat, blood pressure, and cholesterol).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2018

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 27, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 9, 2020

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2020

Completed
Last Updated

June 29, 2022

Status Verified

June 1, 2022

Enrollment Period

2.3 years

First QC Date

July 27, 2018

Last Update Submit

June 23, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Gut microbiome

    abundances of gut microbial taxa, communities, and metabolic pathways activity

    changes from baseline to 12 months

  • Blood metabolome

    abundances of blood metabolites, metabolic networks, and metabolic pathways activity

    changes from baseline to 12 months

Study Arms (2)

KIDFIT Healthy

EXPERIMENTAL
Behavioral: KIDFIT Healthy

KIDFIT Safe

ACTIVE COMPARATOR
Behavioral: KIDFIT Safe

Interventions

KIDFIT HealthyBEHAVIORAL

The KIDFIT Healthy intervention promotes the DASH diet, physical activity, limited screen time, and adequate sleep, through a combination of traditional in-person and electronic participant contacts. See NCT03405246 for details.

Also known as: Intervention Group
KIDFIT Healthy
KIDFIT SafeBEHAVIORAL

The KIDFIT Safe active control provides electronic material about safe home environments and activities (e.g., sun screen, choking hazards, pet safety) for children. See NCT03405246 for details.

Also known as: Control Group
KIDFIT Safe

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \- participating in KIDFIT (NCT03405246)

You may not qualify if:

  • \- none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University Department of Preventive Medicine

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Pediatric Obesity

Interventions

Control Groups

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Amanda Marma Perak, MD MS

    Northwestern University Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in Pediatrics-Cardiology and Preventive Medicine

Study Record Dates

First Submitted

July 27, 2018

First Posted

August 2, 2018

Study Start

July 10, 2018

Primary Completion

November 9, 2020

Study Completion

November 16, 2020

Last Updated

June 29, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

In accordance with the NIH policy to share genomic data from supported studies, raw and processed data from microbiomes, metabolomes, and relevant associated data will be submitted to public data repositories.

Locations